294 related articles for article (PubMed ID: 25737557)
1. Genomically amplified Akt3 activates DNA repair pathway and promotes glioma progression.
Turner KM; Sun Y; Ji P; Granberg KJ; Bernard B; Hu L; Cogdell DE; Zhou X; Yli-Harja O; Nykter M; Shmulevich I; Yung WK; Fuller GN; Zhang W
Proc Natl Acad Sci U S A; 2015 Mar; 112(11):3421-6. PubMed ID: 25737557
[TBL] [Abstract][Full Text] [Related]
2. The role of AKT isoforms in glioblastoma: AKT3 delays tumor progression.
Joy A; Kapoor M; Georges J; Butler L; Chang Y; Li C; Crouch A; Smirnov I; Nakada M; Hepler J; Marty M; Feuerstein BG
J Neurooncol; 2016 Oct; 130(1):43-52. PubMed ID: 27422127
[TBL] [Abstract][Full Text] [Related]
3. Akt2 and Akt3 play a pivotal role in malignant gliomas.
Mure H; Matsuzaki K; Kitazato KT; Mizobuchi Y; Kuwayama K; Kageji T; Nagahiro S
Neuro Oncol; 2010 Mar; 12(3):221-32. PubMed ID: 20167810
[TBL] [Abstract][Full Text] [Related]
4. MicroRNA-203 Modulates the Radiation Sensitivity of Human Malignant Glioma Cells.
Chang JH; Hwang YH; Lee DJ; Kim DH; Park JM; Wu HG; Kim IA
Int J Radiat Oncol Biol Phys; 2016 Feb; 94(2):412-20. PubMed ID: 26678661
[TBL] [Abstract][Full Text] [Related]
5. miR-221/222 promote malignant progression of glioma through activation of the Akt pathway.
Zhang J; Han L; Ge Y; Zhou X; Zhang A; Zhang C; Zhong Y; You Y; Pu P; Kang C
Int J Oncol; 2010 Apr; 36(4):913-20. PubMed ID: 20198336
[TBL] [Abstract][Full Text] [Related]
6. Role of Akt in human malignant glioma: from oncogenesis to tumor aggressiveness.
Chautard E; Ouédraogo ZG; Biau J; Verrelle P
J Neurooncol; 2014 Apr; 117(2):205-15. PubMed ID: 24477623
[TBL] [Abstract][Full Text] [Related]
7. Distinct functional roles of Akt isoforms for proliferation, survival, migration and EGF-mediated signalling in lung cancer derived disseminated tumor cells.
Grabinski N; Bartkowiak K; Grupp K; Brandt B; Pantel K; Jücker M
Cell Signal; 2011 Dec; 23(12):1952-60. PubMed ID: 21777670
[TBL] [Abstract][Full Text] [Related]
8. AKT3 regulates ErbB2, ErbB3 and estrogen receptor α expression and contributes to endocrine therapy resistance of ErbB2(+) breast tumor cells from Balb-neuT mice.
Grabinski N; Möllmann K; Milde-Langosch K; Müller V; Schumacher U; Brandt B; Pantel K; Jücker M
Cell Signal; 2014 May; 26(5):1021-9. PubMed ID: 24463007
[TBL] [Abstract][Full Text] [Related]
9. Genetic driver mutations define the expression signature and microenvironmental composition of high-grade gliomas.
Herting CJ; Chen Z; Pitter KL; Szulzewsky F; Kaffes I; Kaluzova M; Park JC; Cimino PJ; Brennan C; Wang B; Hambardzumyan D
Glia; 2017 Dec; 65(12):1914-1926. PubMed ID: 28836293
[TBL] [Abstract][Full Text] [Related]
10. Sox10 has a broad expression pattern in gliomas and enhances platelet-derived growth factor-B--induced gliomagenesis.
Ferletta M; Uhrbom L; Olofsson T; Pontén F; Westermark B
Mol Cancer Res; 2007 Sep; 5(9):891-7. PubMed ID: 17855658
[TBL] [Abstract][Full Text] [Related]
11. Protein kinase D2 promotes the proliferation of glioma cells by regulating Golgi phosphoprotein 3.
Zhou X; Xue P; Yang M; Shi H; Lu D; Wang Z; Shi Q; Hu J; Xie S; Zhan W; Yu R
Cancer Lett; 2014 Dec; 355(1):121-9. PubMed ID: 25218347
[TBL] [Abstract][Full Text] [Related]
12. Downregulation of AKT3 Increases Migration and Metastasis in Triple Negative Breast Cancer Cells by Upregulating S100A4.
Grottke A; Ewald F; Lange T; Nörz D; Herzberger C; Bach J; Grabinski N; Gräser L; Höppner F; Nashan B; Schumacher U; Jücker M
PLoS One; 2016; 11(1):e0146370. PubMed ID: 26741489
[TBL] [Abstract][Full Text] [Related]
13. AKT2 expression is associated with glioma malignant progression and required for cell survival and invasion.
Zhang J; Han L; Zhang A; Wang Y; Yue X; You Y; Pu P; Kang C
Oncol Rep; 2010 Jul; 24(1):65-72. PubMed ID: 20514445
[TBL] [Abstract][Full Text] [Related]
14. OverAKT3: tumor progression and chemoresistance.
Ji P; Turner KM; Zhang W
Cell Cycle; 2015; 14(13):1993-4. PubMed ID: 25927491
[No Abstract] [Full Text] [Related]
15. Acquired resistance to temozolomide in glioma cell lines: molecular mechanisms and potential translational applications.
Zhang J; Stevens MF; Laughton CA; Madhusudan S; Bradshaw TD
Oncology; 2010; 78(2):103-14. PubMed ID: 20357518
[TBL] [Abstract][Full Text] [Related]
16. All Akt isoforms (Akt1, Akt2, Akt3) are involved in normal hearing, but only Akt2 and Akt3 are involved in auditory hair cell survival in the mammalian inner ear.
Brand Y; Levano S; Radojevic V; Naldi AM; Setz C; Ryan AF; Pak K; Hemmings BA; Bodmer D
PLoS One; 2015; 10(3):e0121599. PubMed ID: 25811375
[TBL] [Abstract][Full Text] [Related]
17. Knockdown of secreted protein acidic and rich in cysteine (SPARC) expression diminishes radiosensitivity of glioma cells.
Liu H; Zhang H; Jiang X; Ma Y; Xu Y; Feng S; Liu F
Cancer Biother Radiopharm; 2011 Dec; 26(6):705-15. PubMed ID: 22145659
[TBL] [Abstract][Full Text] [Related]
18. Downregulation of Src enhances the cytotoxic effect of temozolomide through AKT in glioma.
Wang Z; Sun J; Li X; Yang S; Yue S; Zhang J; Yang X; Zhu T; Jiang R; Yang W
Oncol Rep; 2013 Apr; 29(4):1395-8. PubMed ID: 23338526
[TBL] [Abstract][Full Text] [Related]
19. Glioma derived isocitrate dehydrogenase-2 mutations induced up-regulation of HIF-1α and β-catenin signaling: possible impact on glioma cell metastasis and chemo-resistance.
Fu Y; Zheng S; Zheng Y; Huang R; An N; Liang A; Hu C
Int J Biochem Cell Biol; 2012 May; 44(5):770-5. PubMed ID: 22309944
[TBL] [Abstract][Full Text] [Related]
20. Driver or passenger effects of augmented c-Myc and Cdc20 in gliomagenesis.
Ji P; Zhou X; Liu Q; Fuller GN; Phillips LM; Zhang W
Oncotarget; 2016 Apr; 7(17):23521-9. PubMed ID: 26993778
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]